BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8508815)

  • 1. Cefdinir-induced modification of the susceptibility of bacteria to the antibacterial activity of human serum and polymorphonuclear neutrophils.
    Pruul H; McDonald PJ
    Eur J Clin Microbiol Infect Dis; 1993 Mar; 12(3):170-6. PubMed ID: 8508815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of subinhibitory concentrations of loracarbef (LY 163892) and daptomycin (LY 146032) on bacterial phagocytosis, killing and serum sensitivity.
    Tripodi MF; Adinolfi LE; Utili R; Marrone A; Ruggiero G
    J Antimicrob Chemother; 1990 Oct; 26(4):491-501. PubMed ID: 2174852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meropenem-induced alteration of the susceptibility of Escherichia coli and Staphylococcus aureus to the bactericidal activity of human polymorphonuclear leucocytes.
    Herrera-Insúa I; Pérez P; Martínez P; Gómez-Lus ML; Prieto J
    J Antimicrob Chemother; 1997 Feb; 39(2):223-8. PubMed ID: 9069543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influrence of recombinant human procalcitonin on phagocytic and candidacidal ability of polymorphonuclear leukocytes and on killing mechanisms of serum and blood aganist bacteria Staphylococcus aureus and Escherichia coli].
    Pincíková T; Bucová M; Slobodníková L
    Vnitr Lek; 2005 Dec; 51(12):1365-70. PubMed ID: 16430103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of cefepime on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leucocytes and the determination of this effect by means of nitrite production.
    Sultan N; Cirak MY; Erbaş D
    Microbios; 2000; 103(405):97-106. PubMed ID: 11092191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of bacteria to serum lysis or phagocytosis following growth in subinhibitory levels of lincosaminide or spectinomycin related antibiotics.
    Cialdella JI; Vavra JJ; Marshall VP
    J Antibiot (Tokyo); 1986 Jul; 39(7):978-84. PubMed ID: 2944862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of cefepime by phagocytosing polymorphonuclear neutrophils and subsequent intracellular killing.
    Pruul H; McDonald PJ
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1870-4. PubMed ID: 8843296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism of cephalosporins at subinhibitory concentrations and polymorphonuclear leukocytes on phagocytic killing of Escherichia coli and its mode of action.
    Watanabe Y; Tawara S; Mine Y; Kikuchi H; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1986 Feb; 39(2):294-303. PubMed ID: 3514564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem.
    Adinolfi LE; Bonventre PF
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1012-8. PubMed ID: 3056244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus.
    Veringa EM; Verhoef J
    Chemotherapy; 1987; 33(4):243-9. PubMed ID: 3608624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes.
    Braga PC; Dal Sasso M; Mancini L; Sala MT
    Chemotherapy; 1999; 45(3):166-74. PubMed ID: 10224338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced susceptibility of Escherichia coli to intracellular killing by human polymorphonuclear leukocytes after in vitro incubation with chloramphenicol.
    Pruul H; Wetherall BL; McDonald PJ
    Antimicrob Agents Chemother; 1981 Jun; 19(6):945-51. PubMed ID: 7023384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of cefepime on opsonophagocytosis of bacteria.
    Raponi G; Keller N; Rozenberg-Arska M; Hoepelman IM; Verhoef J
    Drugs Exp Clin Res; 1989; 15(4):141-4. PubMed ID: 2673713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal effect of polymorphonuclear leukocytes on Pseudomonas aeruginosa pre-incubated in ofloxacin.
    Nielsen B; Nielsen H
    Acta Pathol Microbiol Immunol Scand B; 1987 Aug; 95(4):227-32. PubMed ID: 3118637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of two new oral cephalosporins, cefixime and cefdinir (CI 983), on human peripheral mononuclear and polymorphonuclear leukocyte functions.
    Fietta A; Merlini C; Gialdroni Grassi G
    Chemotherapy; 1994; 40(5):317-23. PubMed ID: 7956455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced susceptibility of gram-negative bacteria to phagocytic killing by human polymorphonuclear leucocytes after brief exposure to aztreonam.
    Pruul H; Lewis G; McDonald PJ
    J Antimicrob Chemother; 1988 Nov; 22(5):675-86. PubMed ID: 3209526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibacterial activity of amoxycillin/clavulanic acid against Staphylococcus aureus ingested by human granulocytes.
    Cuffini AM; Tullio V; Allocco A; Paizis G; Carlone NA
    Microbios; 1996; 87(350):31-8. PubMed ID: 8972100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation among cows in the ability of their blood polymorphonuclear leucocytes to kill Escherichia coli and Staphylococcus aureus.
    Williams MR; Bunch KJ
    Res Vet Sci; 1981 May; 30(3):298-302. PubMed ID: 7020019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of serum on the intra- and extracellular bactericidal capacity of neutrophils].
    Sarkisov DS; Pal'tsyn AA; Chervonskaia NV; Badikova AK; Ustinova TS
    Arkh Patol; 1988; 50(7):17-23. PubMed ID: 3190478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefdinir (CI-983), a new oral amino-2-thiazolyl cephalosporin, inhibits human neutrophil myeloperoxidase in the extracellular medium but not the phagolysosome.
    Labro MT; el Benna J; Charlier N; Abdelghaffar H; Hakim J
    J Immunol; 1994 Mar; 152(5):2447-55. PubMed ID: 8133056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.